The UC-Boulder researchers may further be using brain and spinal cord imaging technology in order to determine whether the myelin lesions are being healed in mice who were injected with ATL313. If found to be so, then the said treatment may become a major breakthrough in how doctors may treat the MS symptoms.
The results were quite surprising for the researchers since they initially conducted the study to determine the drugs potential in treating MS associated pain which affects 70 to 80 percent of MS patients. Their initial thought was that this class of compounds would calm down the glial cells in the spinal cord since their activation is related to the cause of pain.
Users browsing this forum: No registered users